CICC in­vests $238M in Con­cord Med­i­cal

BioSpectrum (Asia) - - Finance News -

CICC Cap­i­tal Man­age­ment Com­pany Limited, a whol­ly­owned sub­sidiary of China In­ter­na­tional Cap­i­tal Cor­po­ra­tion Limited (CICC), has made a strate­gic in­vest­ment be­tween $238 mil­lion and $286 mil­lion in Con­cord Med­i­cal’s sub­sidiary, Bei­jing Meizhong Ji­ahe Hos­pi­tal Man­age­ment Co., Ltd. The in­vestors will hold 37.5 to 41.9 per cent of Meizhong Ji­ahe’s eq­uity af­ter the in­vest­ment.

Con­cord Med­i­cal Ser­vices Hold­ings Limited is a lead­ing spe­cialty hos­pi­tal man­age­ment so­lu­tions provider and op­er­a­tor of a net­work of ra­dio­ther­apy and di­ag­nos­tic imag­ing cen­ters in China. As the most im­por­tant op­er­at­ing plat­form of Con­cord Med­i­cal in China, Meizhong Ji­ahe has been com­mit­ted to in­vest­ing in the op­er­a­tion of can­cer di­ag­no­sis and treat­ment cen­ters na­tion­wide. It has de­vel­oped into a na­tion­wide hos­pi­tal man­age­ment group and a net­work of in­de­pen­dent spe­cialty can­cer hos­pi­tals lo­cated in Bei­jing, Shang­hai and Guangzhou, with an em­pha­sis on high-end spe­cialty can­cer hos­pi­tals, in­clud­ing sec­ondary spe­cialty can­cer hos­pi­tals and pro­ton ther­apy treat­ment.

With the aim of en­sur­ing tech­ni­cal train­ing, pro­mot­ing med­i­cal qual­ity and strength­en­ing hos­pi­tal man­age­ment, Meizhong Ji­ahe will pro­vide high-qual­ity med­i­cal ser­vices for pa­tients.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.